← Leaderboards
Candace McNaughton
Vanderbilt University
$487,967
Attributed
$487,967
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $172.2K · FY2015–17$200K$150K$100K$50K$0
'15
'16
'17
Funding mix
By agency
NIH$487,967 · 1
By mechanism
K23$487,967 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Terence S. Dermody$49,981,852
- Roy A. Jensen$20,860,843
- Russell L. Rothman$12,060,223
- Qi Dai$8,521,639
- David H Johnson$5,849,161
Others in their field
Top investigators on “Clinic”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,108,147,906
- Leonard Freedman · Leidos Biomedical Research, Inc.$978,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$798,941,641
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$639,436,363
- Barton F Haynes · Duke University$546,907,423
Research focus
ClinicChronicAccountabilityCharacteristicsAccident And Emergency DepartmentAfrican AmericanAmericanAntihypertensive AgentsAdverse EffectsBehaviorAffectBehavioral Health InterventionBehavioral ResearchBehavior TherapyBlood PressureBlood Pressure RegulationBlood TestsCardiovascular DiseasesBaseCardiovascular SystemCareerCareer DevelopmentCare SeekingClinical Research
Grant awards (3)
A Randomized, ED-based Intervention to Improve Antihypertensive Adherence$171,404
K23 · FY2017 · HL · contact PI
A Randomized, ED-based Intervention to Improve Antihypertensive Adherence$172,249
K23 · FY2016 · HL · contact PI
A Randomized, ED-based Intervention to Improve Antihypertensive Adherence$144,314
K23 · FY2015 · HL · contact PI